Patent US4197312A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4197312A Expired / Lapsed US ⏱️ 0.0 years remaining

Alkali metal and alkaline earth metal salts of benzoylacetonitriles

Assignee: Wyeth Holdings LLC
•
Filing: 1978-05-09
•
Granted: 1980-04-08
•
Expires: 1998-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure describes new compounds and compositions of matter useful as anti-inflammatory agents and as inhibitors of the progressive joint deterioration characteristic of arthritic disease and the methods of meliorating inflammation and of inhibiting joint deterioration in mammals therewith, the novel active ingredients of said compositions of matter being the pharmacologically acceptable cationic salts of benzoylacetonitrile, o-fluorobenzoylacetonitrile, m-fluorobenzoylacetonitrile, p-fluorobenzoylacetonitrile, or mixtures thereof.

Inventors

  • 👤 Adolph E. Sloboda
  • 👤 John W. Hanifin, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 13:56
CPC Classifications
C; C07; C07C; C07C255/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 48 words
The method of inhibiting the progression of arthritis in a mammal which comprises administering to said mammal an effective amount of a compound of the formula: ##STR4## wherein R is hydrogen or fluoro, M is a pharmacologically acceptable cation, and n is an integer from 1 to 3.
Claim 2
Independent Claim 48 words
The method of inhibiting the progression of arthritis in a mammal which comprises administering to said mammal an effective amount of a compound of the formula: ##STR4## wherein R is hydrogen or fluoro, M is a pharmacologically acceptable cation, and n is an integer from 1 to 3.
Claim 3
Independent Claim 47 words
The method of inhibiting progressive joint deterioration in a mammal which comprises administering to said mammal an effective amount of a compound of the formula: ##STR5## wherein R is hydrogen or fluoro, M is a pharmacologically acceptable cation, and n is an integer from 1 to 3.
Claim 4
Independent Claim 47 words
The method of inhibiting progressive joint deterioration in a mammal which comprises administering to said mammal an effective amount of a compound of the formula: ##STR5## wherein R is hydrogen or fluoro, M is a pharmacologically acceptable cation, and n is an integer from 1 to 3.
Claim 5
Independent Claim 45 words
The method of meliorating inflammation in a mammal which comprises administering to said mammal an effective amount of a compound of the formula: ##STR6## wherein R is hydrogen or fluoro, M is a pharmacologically acceptable cation, and n is an integer from 1 to 3.
Claim 6
Independent Claim 45 words
The method of meliorating inflammation in a mammal which comprises administering to said mammal an effective amount of a compound of the formula: ##STR6## wherein R is hydrogen or fluoro, M is a pharmacologically acceptable cation, and n is an integer from 1 to 3.

References Cited (Backward Citations)

US3763285A Cited
US3775517A Cited
DE2302273A1 Cited
DE2409462A1 Cited
US4083993A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-04-08 1983-10-08 1984-04-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-04-08 1987-10-08 1988-04-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-04-08 1991-10-08 1992-04-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag